CSIMarket
 
Tandem Diabetes Care Inc   (NASDAQ: TNDM)
Other Ticker:  
 
 

Tandem Diabetes Care Inc Growth Comparisons

Select each growth Category to receive further Information



TNDM Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 24.48 % 1.71 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 9.86 % -0.05 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 5.69 % 3.54 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 6.09 % 0.09 % 1.77 % 1.08 %
Revenue 5 Year Average Growth 32.39 % 6.53 % 7.98 % 7.75 %


TNDM's Growth Comparisons in III. Quarter 2024




With 24.48% year on year Revenue increase in the third quarter 2024, Tandem Diabetes Care Inc outperformed the 1.71% growth in the Medical Equipment & Supplies industry, and 7.3% growth in the Healthcare sector. Although the Medical Equipment & Supplies industry's Sales gains were softer then 3.85% overall market growth, Tandem Diabetes Care Inc and the Healthcare sector have delivered above average market Sales growth.

Comparing the company's Revenue to the second quarter results, sales were higher by 9.86% . On the yearly basis, average annual sales growth for Tandem Diabetes Care Inc is 32.39%, while S & P 500's including only Businesses with the third quarter 2024 earnings, average annual sales growth is 7.75% over the past five years.

TNDM Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
United States
31.81 %
9.53 %
Outside the United States
30.54 %
-67.41 %
Pump
30.4 %
6.42 %
Supplies and other
21.08 %
12.51 %
Net revenue recognized deferred for Tandem Choice program
-
-
Total
-
9.86 %


Growth Rates of TNDM's Income in the third quarter 2024


TNDM Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 185.03 % 80.05 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) - 27.33 % 33.32 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) - 256.02 % -5.83 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) - 24.17 % 19.93 % 1.36 %
Operating Income 5 Year Avg. Change - -11.82 % 6.19 % 9.17 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 352.55 % 285.84 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 42.14 % 119.47 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 584.47 % 26.31 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 33.42 % 56.61 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change - -14.3 % -9.67 % 7.35 %

TNDM Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 132.62 % 8.01 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) - 90.6 % 133.05 % -6.89 %
Y / Y Net Income Change (Q3 TTM) - 321.07 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) - 29.69 % 2.56 % -1.41 %
Net Income 5 Year Avg. Growth - -10.65 % -3.34 % 7.5 %

TNDM's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 593.83 % 285.84 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 53.42 % 119.47 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -26.13 % -9.67 % 7.35 %



TNDM EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 256.65 % 8.01 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) - 105.72 % 133.05 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - -10.65 % -3.34 % 7.5 %



Tandem Diabetes Care Inc reported bottom-line of $ -0.35 in the third quarter, compare to $ -0.55 in the same quarter a year ago. Medical Equipment & Supplies industry grew by 256.65%, while Healthcare sector increased by 8.01%, and overall market declined by -6.44%.

Comparing company's EPS to the second quarter results, income per share were higher by 9.86% . On the yearly basis, average annual income per share growth for Tandem Diabetes Care Inc is 32.39%, while S & P 500's including only the businesses with the third quarter 2024 Results, average annual income per share growth is 7.5% over the past five years.

TNDM Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -21.14 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) - -13.87 % 107.49 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) 24.11 % -0.85 % 4.24 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) - -5.94 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change - 1.78 % 7.1 % 11.97 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) -55.1 % - -79.59 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - -82.12 % - -
Seq. Net Cash Flow Change (Q3 TTM) - -92.65 % - -
Net Cash Flow 5 Year Avg. Change - - 10.99 % -33.52 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -28.98 % -7.78 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) -18.98 % 1.35 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) -24.71 % -1.35 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) -7.4 % -2.43 % 2.03 % -0.5 %
Capital Expenditures 5 Year Avg. Change 55.1 % 10.29 % 9.35 % 8.86 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com